INSIGHTS ON UPSTREAM MANUFACTURING
-
Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors
Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.
-
Develop Clones In Just 9 Weeks From Transfection With Up To 4X Titer
Transposon-based cell line development cuts timelines by 10 weeks and hits titers of 4.8 g/L in 17 days. See how SynWeave delivers measurable biologics manufacturing gains.
-
Direct Scale Up From Clone To 2K GMP Batches
N-1 perfusion technology increased antibody titers 1.5–4.5x over conventional fed-batch methods. See how high seed density and media blending cut costs and maximize suite utilization.
-
Why Use Pseudomonas Flourescens For Protein Expression?
Choosing the right microbial host for protein expression can define downstream success or failure. Not all organisms are built for production, and the difference matters at scale.
-
Applying ncAA Incorporation To CRM197 Vaccine Carrier Protein Engineering6/10/2026
Achieving precise, site-specific conjugation on vaccine carrier proteins requires careful structural analysis to avoid disrupting critical functional regions and immune response pathways.
-
iPSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers6/10/2026
Controlled aggregation, oxygen management, and scalable workflows drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster optimization and confident transitions.
-
Efficient Monitoring Of Escherichia Coli Feeding Strategies6/10/2026
Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.
-
Monitoring Of A pH Optimization Approach For CHO Cell Cultivation6/10/2026
Cloud-based monitoring and analytics help centralize data, gain real-time insight, and improve decision-making. Enhanced visibility and collaboration enable faster optimization and consistency across development and manufacturing.
UPSTREAM MANUFACTURING SOLUTIONS
-
See early-stage CDMO capabilities at a specialized bio campus, detailing process development, analytical support, bioconjugation services, cell banking, and scalable manufacturing solutions.
-
Bioprocessing is at the heart of many industries and Eppendorf has the right solutions for all of them.
-
Higher cell density and improved process consistency start with the right growth environment. This structured cell attachment helps streamline scale-up with unique protection to maintain strong viability across demanding bioprocess applications.
-
Flexible bioprocess control enables seamless transitions from development to scale, combining automation, intuitive operation, and precise environmental management to improve efficiency, reproducibility, and adaptability.
-
Modern bioprocessing depends on adaptable, precise equipment that supports scalability and consistency. Discover how to streamline workflows, reduce risk, and maintain control across up- and downstream operations.